康恩贝：公司系统规划并着力打造四大核心能力

Core Viewpoint - The essence of the company's "anti-involution" strategy lies in continuously building irreplaceable core competencies, focusing on four key capabilities to strengthen its development foundation and competitive barriers [1] Group 1: Core Competencies - The company is systematically planning and focusing on four core capabilities: brand building in the health sector, forward-looking research and pipeline layout, comprehensive professional compliance promotion across channels, and a stable and efficient supply chain [1] Group 2: Revenue Growth Strategies - The company is pursuing both intrinsic growth and extrinsic expansion as dual drivers for revenue growth [1] - For intrinsic growth, the company aims to consolidate the leadership of its flagship products such as Changyanning, Qianlikang, and Zhixinfu, while exploring growth opportunities for potential products like Jindi, Niuhuang Shangqing capsules, and Jinaikang [1] - The company is also focused on identifying market opportunities and enhancing its research and development layout to strengthen its advantages in traditional Chinese medicine and actively pursue innovative drug development [1] Group 3: External Expansion - In terms of extrinsic expansion, the company plans to engage in equity mergers and acquisitions related to traditional Chinese medicine and rapidly acquire potential products through systematic business development [1]